Apolipoprotein E e4 Allele Is Associated with Subjective Cognitive Decline: A Meta-Analysis
Ting Zhang1,2, Shuling Liu1,2, Yajing Zhang1,2
1Department of Neurology, Tianjin, China.
This meta-analysis found a weak link between the Apolipoprotein E e4 (APOE e4) allele and Subjective Cognitive Decline (SCD). Age and geographic region significantly influenced the prevalence of APOE e4 in individuals with SCD.
Area of Science:
- Neurology
- Genetics
- Epidemiology
Background:
- Subjective Cognitive Decline (SCD) is a precursor to Alzheimer's disease.
- The Apolipoprotein E e4 (APOE e4) allele is a known genetic risk factor for Alzheimer's disease.
Purpose of the Study:
- To estimate the prevalence of the APOE e4 allele in individuals with SCD.
- To determine the association between APOE e4 and SCD through a meta-analysis.
Main Methods:
- A meta-analysis of 28 studies was conducted, including 6,044 individuals with SCD.
- Searched MEDLINE, EMBASE, and Cochrane Library databases.
- Stratified and meta-regression analyses were used to address heterogeneity.
Main Results:
- The APOE e4 allele showed a weak association with SCD (OR 1.12).
- The pooled prevalence of APOE e4 carriers among individuals with SCD was 32%.
- Age and northern European residency were identified as significant factors contributing to heterogeneity.
Conclusions:
- A weak association exists between APOE e4 and SCD.
- Age and geographic factors (northern European residency) are critical in understanding the heterogeneity of APOE e4 prevalence in SCD.
More Related Videos
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Cognitive Development During Adulthood
